← FDA DRUG APPROVALS

FDA ANDA · ANDA209741

NEBIVOLOL HYDROCHLORIDE

Sponsor: APOTEX

APPLICATION
ANDA209741
TYPE
ANDA
ORIGINAL APPROVAL
2024-02-27
LATEST ACTION
2024-02-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL
NEBIVOLOL HYDROCHLORIDEDiscontinued
NEBIVOLOL HYDROCHLORIDE EQ 20MG BASE · TABLET · ORAL

Approval history

2024-02-27UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →